These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 2491829

  • 21. Effect of lithium carbonate on the neutropenia caused by chemotherapy: a preliminary clinical trial.
    Greco FA, Brereton HD.
    Oncology; 1977; 34(4):153-5. PubMed ID: 917447
    [Abstract] [Full Text] [Related]

  • 22. Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.
    Ohno R, Yokomaku S, Okumara M, Tanimoto M, Morishita Y, Morishima Y, Kodera Y, Saito H.
    Haematol Blood Transfus; 1990; 33():304-8. PubMed ID: 2182424
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.
    Damon LE, Rugo HS, Ries CA, Linker CA.
    Leukemia; 1994 Apr; 8(4):535-41. PubMed ID: 8152248
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Induction and intensive combined therapy of acute myeloid leukemia in adults].
    Kurrle E, Ehninger G, Freund M, Heil G, Hoelzer D, Link H, Mitrou PS, Ohl S, Queisser W, Schlimok G.
    Onkologie; 1988 Feb; 11(1):5-9. PubMed ID: 3283626
    [Abstract] [Full Text] [Related]

  • 30. The effect of lithium on haematopoiesis of patients with acute myeloid leukaemia.
    Korycka A, Robak T.
    Arch Immunol Ther Exp (Warsz); 1991 Feb; 39(5-6):501-9. PubMed ID: 1841548
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
    Volger WR, Weiner RS, Moore JO, Omura GA, Bartolucci AA, Stagg M.
    Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
    [Abstract] [Full Text] [Related]

  • 36. A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.
    Derbel O, Cannas G, Le QH, Elhamri M, Chelghoum Y, Nicolas-Virelizier E, Nicolini F, Troncy J, Barraco F, Michallet M, Thomas X.
    Hematology; 2010 Jun; 15(3):125-31. PubMed ID: 20557669
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Granulocyte-macrophage colony stimulating factor treatment of febrile neutropenia following remission induction chemotherapy for acute leukemia.
    Cucuianu A, Petrov L, Ghiurt A, Vasilache A.
    Rom J Intern Med; 1996 Jun; 34(1-2):97-103. PubMed ID: 8908636
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.